<DOC>
	<DOCNO>NCT01374971</DOCNO>
	<brief_summary>The purpose study conduct Investigator-Sponsored Study determine potential immunomodulatory effect Certolizumab Pegol ( CZP ) treatment site disease activity ( synovial lining ) subject rheumatoid arthritis ( RA ) , use pre treatment post treatment arthroscopic synovial biopsy ex vivo gene expression .</brief_summary>
	<brief_title>Rheumatoid Arthritis Treatment Biopsy Study Assessing Certolizumab Pegol ( Cimzia )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Certolizumab Pegol</mesh_term>
	<criteria>Signed date informed consent document Subjects must least 18 year age old Subject must willing able comply schedule visit , arthroscopy , laboratory test , procedure Diagnosis RA base American College Rheumatology ( ACR ) 1987 Revised Criteria Active disease screen visit Methotrexate take continuously least 12 week stable dosage Sexually active woman childbearing potential men whose partner woman childbearing potential require use adequate contraceptive method participation trial Treatment nonsteroidal antiinflammatory drug ( NSAIDS ) oral corticosteroid ( less equal 10 mg/day prednisone equivalent ) accept Diagnosis inflammatory arthritis History infect joint prosthesis still situ History allergy local anesthetic agent Pregnant lactate woman Current recent history uncontrolled clinically significant condition ( e.g.. , kidney disease , liver disease , class III IV congestive heart failure , accord New York Heart Association ) History suspect demyelinate disease central nervous system , e.g . multiple sclerosis optic neuritis Current participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Cimzia</keyword>
	<keyword>Certolizumab Pegol</keyword>
	<keyword>Arthroscopic Synovial biopsy</keyword>
	<keyword>Office Based Procedure</keyword>
	<keyword>Biologic</keyword>
	<keyword>Tumor Necrosis Factor ( TNF )</keyword>
	<keyword>Anti-TNF</keyword>
</DOC>